• 1628 Citations
  • 23 h-Index
1987 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Takeshi Suzuki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Acetylcholine Medicine & Life Sciences
Inbred SHR Rats Medicine & Life Sciences
tetrandrine Medicine & Life Sciences
Japan Medicine & Life Sciences
Antihypertensive Agents Medicine & Life Sciences
Blood Pressure Medicine & Life Sciences
Stroke Medicine & Life Sciences
Cholinergic Agents Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2019

  • 1628 Citations
  • 23 h-Index
  • 78 Article

Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy

Shibata, S., Fukumoto, D., Suzuki, T. & Ozaki, K., 2019 Jan 1, (Accepted/In press) In : Therapeutic Innovation and Regulatory Science.

Research output: Contribution to journalArticle

Japan
Costs and Cost Analysis
Pharmaceutical Preparations
Health Expenditures
Drug Costs
1 Citation (Scopus)

Anticancer Drug Prescription Patterns in Japan: Future Directions in Cancer Therapy

Shibata, S., Matsushita, M., Saito, Y. & Suzuki, T., 2018 Nov 1, In : Therapeutic Innovation and Regulatory Science. 52, 6, p. 718-723 6 p.

Research output: Contribution to journalArticle

Drug Prescriptions
Japan
Pharmaceutical Preparations
Neoplasms
Health Expenditures

An empirical study of the prescription pattern of drugs for hematological malignancies in Japan from 2010-2014

Shibata, S., Wayama, Y., Tsuyuki, A., Matsushita, M., Chiba, K., Matsuki, E., Okamoto, S. & Suzuki, T., 2017, In : Biological and Pharmaceutical Bulletin. 40, 6, p. 894-901 8 p.

Research output: Contribution to journalArticle

Prescription Drugs
Hematologic Neoplasms
Japan
Pharmaceutical Preparations
Pharmaceutical Databases
1 Citation (Scopus)

CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients

Matsushita, M., Ozawa, K., Suzuki, T., Nakamura, M., Nakano, N., Kanchi, S., Ichikawa, D., Matsuki, E., Sakurai, M., Karigane, D., Kasahara, H., Tsukamoto, N., Shimizu, T., Mori, T., Nakajima, H., Okamoto, S., Kawakami, Y. & Hattori, Y., 2017 Sep 1, In : Blood Cancer Journal. 7, 9, e601.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Stem Cells
Therapeutics
T-Lymphocytes
Japan
Pharmaceutical Preparations
Generic Drugs
Linear Models